Development of a City-Wide Cohort of HIV-Infected Persons in Care in the District of Columbia: The DC Cohort
The goal of the DC Cohort is to establish a clinic-based city-wide longitudinal cohort that will describe clinical outcomes, and improve the quality of care for patients diagnosed with Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome (HIV/AIDS) or at higher risk for acquiring HIV and receiving care in Washington, DC.
• Patient is receiving care for HIV at one or more of the twelve participating clinics in the DC Cohort.
• Patient is either age 18 years or older, or seeks HIV care independently and is able to understand and sign informed consent.
• Patient is a minor who is consented by a parent or legal guardian.
∙ Persons receiving any antiretroviral prescription without evidence of HIV or Hepatitis B infection
• PrEP (e.g., TDF/FTC, Descovy, Apretude)
• Combination ART indicative of nPEP in an HIV-uninfected person
• Persons receiving an antiretroviral prescription indicative of DoxyPEP Doxycycline 200mg PO taken within 72 hrs of unprotected sexual encounter (or variations thereof where clearly not prescribed as a treatment course)
• Test positive for ≥1 bacterial STI (positive gonorrhea (GC/NG) or chlamydia (CT) test or positive syphilis test requiring treatment within one year)
‣ 2 bacterial STI (GC, chlamydia, syphilis) tests at 2 or more different encounters
⁃ 2 HIV tests at 2 or more different encounters
• Patient requesting PrEP at their clinical visit
• Patient requesting nPEP at their clinical visit
• People who identify as injecting drugs
∙ Patients with a Z29.81 Encounter for HIV pre-exposure prophylaxis